Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. That said, here are three profitable companies to steer clear of and a few better alternatives.
Ameresco (AMRC)
Trailing 12-Month GAAP Operating Margin: 6%
Having played a role in upgrading the energy solutions of Alcatraz Island, Ameresco (NYSE: AMRC) provides energy and renewable energy solutions for various sectors.
Why Is AMRC Not Exciting?
- Issuance of new shares over the last five years caused its earnings per share to fall by 12% annually while its revenue grew
- Cash-burning tendencies make us wonder if it can sustainably generate shareholder value
- Limited cash reserves may force the company to seek unfavorable financing terms that could dilute shareholders
At $36.21 per share, Ameresco trades at 31.4x forward P/E. Check out our free in-depth research report to learn more about why AMRC doesn’t pass our bar.
Encompass Health (EHC)
Trailing 12-Month GAAP Operating Margin: 18.1%
With a network of 161 specialized facilities across 37 states and Puerto Rico, Encompass Health (NYSE: EHC) operates inpatient rehabilitation hospitals that help patients recover from strokes, hip fractures, and other debilitating conditions.
Why Do We Think Twice About EHC?
- Annual revenue growth of 6.5% over the last five years was below our standards for the healthcare sector
- Disappointing comparable store sales over the past two years show customers aren’t responding well to its offerings and value proposition
Encompass Health’s stock price of $101.55 implies a valuation ratio of 16.8x forward P/E. To fully understand why you should be careful with EHC, check out our full research report (it’s free).
Booz Allen Hamilton (BAH)
Trailing 12-Month GAAP Operating Margin: 9.2%
With roots dating back to 1914 and deep ties to nearly all U.S. cabinet-level departments, Booz Allen Hamilton (NYSE: BAH) provides management consulting, technology services, and cybersecurity solutions primarily to U.S. government agencies and military branches.
Why Does BAH Give Us Pause?
- Large revenue base makes it harder to increase sales quickly, and its annual revenue growth of 2.6% over the last two years was below our standards for the business services sector
- Anticipated sales growth of 1.5% for the next year implies demand will be shaky
- Earnings growth underperformed the sector average over the last two years as its EPS grew by just 8.9% annually
Booz Allen Hamilton is trading at $82.07 per share, or 13.4x forward P/E. Dive into our free research report to see why there are better opportunities than BAH.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
